基于超声造影的超声组学评分:预测肝细胞癌切除或消融后早期复发的潜在生物标志物
本研究回顾性纳入215例原发性肝细胞癌患者,分为开发队列139例和测试队列76例,从超声造影视频提取肿瘤及瘤周区域的超声组学特征,构建肿瘤模型、瘤周模型及联合临床危险因素的联合模型。联合模型预测2年内复发的AUC为0.845,优于肿瘤模型(AUC 0.810)和瘤周模型(AUC 0.808)。高风险组2年累积复发率76.5%,显著高于低风险组的9.5%(p < 0.0001)。
要点
- 联合模型预测肝细胞癌切除或消融后2年内复发的AUC为0.845,优于肿瘤模型(0.810)和瘤周模型(0.808)。
- 高风险组2年累积复发率为76.5%,低风险组为9.5%,两组差异有统计学意义(p < 0.0001)。
- 超声组学在诊断肝细胞癌早期复发方面具有高敏感度、特异度和阳性预测值,预测早期复发的AUC > 0.8。
核心结论
- 基于超声造影的超声组学模型,尤其是联合模型,在预测肝细胞癌切除或消融后早期复发方面具有良好的效能,并可能用于个体化生存评估。
研究设计与样本
- 回顾性研究,纳入215例原发性肝细胞癌患者,分为开发队列(n = 139)和测试队列(n = 76);从每例超声造影视频中提取灰阶超声、动脉期、门静脉期和延迟期四幅代表性图像,提取肿瘤及瘤周区域的超声组学特征,采用逻辑回归建立肿瘤模型、瘤周模型及联合临床危险因素的联合模型,验证三种模型预测2年内复发的效能。
诊断标准与关键数值
- 联合模型预测2年内复发的AUC为0.845。
- 肿瘤模型预测2年内复发的AUC为0.810。
- 瘤周模型预测2年内复发的AUC为0.808。
- 超声组学诊断肝细胞癌早期复发具有高敏感度、特异度和阳性预测值,预测早期复发的AUC > 0.8。
临床应用与阅片要点
- 作者认为超声组学模型,尤其是联合模型,在预测肝细胞癌切除或消融后早期复发方面具有良好的效能,并可能用于个体化生存评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to construct a prediction model based on contrast-enhanced ultrasound (CEUS) ultrasomics features and investigate its efficacy in predicting early recurrence (ER) of primary hepatocellular carcinoma (HCC) after resection or ablation.
METHODS: This study retrospectively included 215 patients with primary HCC, who were divided into a developmental cohort (n = 139) and a test cohort (n = 76). Four representative images-grayscale ultrasound, arterial phase, portal venous phase and delayed phase-were extracted from each CEUS video. Ultrasomics features were extracted from tumoral and peritumoral area inside the region of interest. Logistic regression was used to establish models, including a tumoral model, a peritumoral model and a combined model with additional clinical risk factors. The performance of the three models in predicting recurrence within 2 years was verified.
RESULTS: The combined model performed best in predicting recurrence within 2 years, with an area under the curve (AUC) of 0.845, while the tumoral model had an AUC of 0.810 and the peritumoral model one of 0.808. For prediction of recurrence-free survival, the 2-year cumulative recurrence rate was significant higher in the high-risk group (76.5%) than in the low-risk group (9.5%; p < 0.0001).
CONCLUSION: These CEUS ultrasomics models, especially the combined model, had good efficacy in predicting early recurrence of HCC. The combined model has potential for individual survival assessment for HCC patients undergoing resection or ablation.
ADVANCES IN KNOWLEDGE: CEUS ultrasomics had high sensitivity, specificity and PPV in diagnosing early recurrence of HCC, and high efficacy in predicting early recurrence of HCC (AUC > 0.8). The combined model performed better than the tumoral ultrasomics model and peritumoral ultrasomics model in predicting recurrence within 2 years. Recurrence was more likely to occur in the high-risk group than in the low-risk group, with 2-year cumulative recurrence rates, respectively, 76.5% and 9.5% (p < 0.0001).
引用
- Huang, Ruan, Xian, et al. Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation. Br J Radiol. 2021. PMID: 34797687. doi:10.1259/bjr.20210748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。